Percutaneous closure of secundum type atrial septal defects: More than 5-year follow-up

Table 1 Basline characteristics

Number	104
Age (yr)	45.5 ± 17.1
Female, n (%)	78 (75.0)
Weight (kg)	73.1 ± 15.1
Risk factors and co-morbidities (%)
Arterial hypertension	18.4
Hypercholesterolemia	3.9
Diabetes	1.9
Smoking	18.4
CAD	4.9
History of SVT	26.2
Antithrombotic treatment, n (%)
None	59 (56.7)
Aspirin	20 (19.2)
Dipyridamol	1 (1.0)
Oral anticoagulants	21 (20.2)
Unknown	3 (2.9)
Indication for closure, n (%)
RV volume overload	72 (69.2)
Cryptogenic TIA/stroke	21 (20.2)
Asymptomatic	11 (10.6)
RVSP + CVP (mmHg)1	34.6 ± 10.5
ASD diameter (mm)2	18.3 ± 6.3
Follow up (yr)	6.4 ± 3.4

Data are presented as mean ± SD.

¹On transthoracic echocardiography;

²On transesophageal echocardiography. CAD: Coronary artery disease; SVT: Supraventricular arrhythmia; TIA: Transient ischemic attack; RVSP: Right ventricular systolic pressure; CVP: Central venous pressure; ASD: Atrial septal defect.